Company news

Zelira Therapeutics Ltd. news in 2016

Zelira Therapeutics Ltd.'s news releases, calls and decks from 2016, newest first.

View company

Zelda to Test Formulations Against Pancreatic Cancer

December 19, 2016

Sleep Disorder Clinical Trials Update

December 11, 2016

Collaboration Agreement with Telethon Kids Institute

December 4, 2016

Significant Anti-Cancer Effect Observed in Studies

November 29, 2016

Zelda expands its Intellectual Property portfolio

November 24, 2016

OpenBriefing Recording with Dr Stewart Washer

November 23, 2016

Reinstatement to Official Quotation - 22 November 2016

November 18, 2016

Suspension from Official Quotation

July 25, 2016

Prospectus

July 11, 2016

Consolidation/Split - GLN

June 28, 2016

Successful Completion of Pre-IPO Capital Raise

May 30, 2016

Quarterly Activities Report

April 29, 2016

Quarterly Cashflow Report

February 11, 2016

Gleneagle to Acquire Zelda Therapeutics Pty Ltd

February 10, 2016

Decks in 2016